L-leucine, an FDA-approved compound, exerts neuroprotective effects in Parkinson’s disease models. By reducing alpha-synuclein aggregation and restoring dopamine signaling, NALL targets multiple ...

Northwestern Medicine scientists have discovered that an FDA-approved compound promotes neuroprotective effects in experimental models of Parkinson's disease. The compound, N-acetyl-L-leucine (NALL), ...

ProMIS Neurosciences, Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing next-generation therapies for Alzheimer’s disease (AD) and other neurodegenerative disorders, today ...

A new UCLA Health study suggests that long-term exposure to the pesticide chlorpyrifos may dramatically raise the risk of Parkinson’s disease. Researchers found that people living in areas with ...

An international team led by researchers from the University Medical Center Göttingen (UMG), Germany, has used advanced ...

Long-term exposure to the pesticide chlorpyrifos was associated with more than a 2.5-fold higher risk of Parkinson’s disease. The study combined hu ...

Tiny plastic particles may be quietly threatening brain health. New research suggests microplastics—now widely found in food, ...

ProMIS Neurosciences, Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing next-generation therapies for Alzheimer's disease ...

A growing body of research into Parkinson’s disease is challenging the assumption that the condition looks the same in every ...

Partnership supports expanded biomarker discovery efforts within MJFF's Parkinson's Progression Markers Initiative MORRISVILLE, N.C., March 17, 2026 /PRNewswire/ -- Metabolon, Inc., the global leader ...

Researchers identified TBC1D9B as the off switch for ARL8B, a key regulator of lysosome positioning. This mechanism controls how cells adapt to nutrient stress and maintain metabolic balance.